ArticleThe Journal of clinical investigation2004

Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VII.

Paris Margaritis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.